The APPRISE Centre of Research Excellence is developing research to inform Australia’s emergency response to infectious diseases
Our work impacts both children and adults and focuses on working with populations who are potentially at higher risk of infectious diseases. These communities include Aboriginal and Torres Strait Islander peoples, refugees and other socially vulnerable or disadvantaged groups.
APPRISE COVID-19 updates:
- Fast-tracked new COVID-19 projects meet areas of urgent need
- Paul Ramsay Foundation commits $2m to support APPRISE COVID-19 research with First Nations peoples
- NHMRC gives $2m for COVID-19 research in areas of urgent need
- Snow Medical Research Foundation invests in COVID-19 research funding
APPRISE CRE works on a range of high-impact infectious diseases
- novel coronavirus disease (COVID-19) caused by the SARS-CoV-2 virus
- Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- Middle East Respiratory Coronavirus (MERS-CoV)
- haemorrhagic viruses including Ebola virus (EBOV)
- vector-borne pathogens including arboviruses such as Zika virus
- bacterial diseases such as Meningococcal W disease
- animal pathogens of relevance to humans.